Small Dense Low-Density Lipoprotein (sdLDL)
Small dense LDL particles possess high arterial wall permeability, reduced LDL receptor affinity, and increased susceptibility to oxidative modification compared to large buoyant LDL.
Standard vs. Optimal Reference Rangesmg/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
< 21 mg/dL
General reference distribution across unselected commercial populations.
< 10 mg/dL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Due to reduced particle radius, sdLDL penetrates the endothelial barrier into the arterial subintimal space with three-fold higher efficiency than buoyant LDL, where its exposed proteoglycan-binding domains bind extracellular matrix glycosaminoglycans.
Differential Diagnosis
Elevated Levels (sdLDL High)
- •Hypertriglyceridemic insulin resistance
- •Type 2 Diabetes Mellitus
- •High glycemic carbohydrate intake
Low Levels (sdLDL Low)
- •Insulin-sensitive pattern A lipid profile
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Standard testing requires a 10 to 12 hour overnight fast to minimize postprandial chylomicron interference, although sdLDL direct immunoassay is less sensitive to prandial state than calculated LDL-C. Avoid strenuous high-intensity exercise 24 hours prior to blood draw. Serum separator tubes (SST) or EDTA plasma should be centrifuged within 2 hours. High-dose biotin (>5 mg/day) supplementation may interfere with competitive streptavidin-biotin immunoassays, requiring a 48-hour washout period.
Reflexive Testing Protocol:
- Advanced Lipoprotein Particle Quantification (NMR spectroscopy or ion mobility LDL-P)
- Lipoprotein(a) [Lp(a)] baseline evaluation for genetic cardiovascular risk stratification
- Coronary Artery Calcium (CAC) score via non-contrast cardiac CT to evaluate calcified plaque burden
- High-sensitivity C-Reactive Protein (hs-CRP) to assess systemic vascular inflammatory tone
- Carotid intima-media thickness (CIMT) duplex ultrasound to assess subclinical atherosclerosis
Clinical Citations & Primary Literature (1)
- [1]Small Dense Low-Density Lipoprotein Cholesterol and Atherosclerotic Events - JACC (2020). PMID: 32703512
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Small Dense Low-Density Lipoprotein (sdLDL) into overall healthspan optimization.